000			03376nam a22003137a 4500
001			CUHAS/MD/4000901/T/12
003			CUHAS/MD/4000901/T/12
005			20240305193820.0
008			210802b |||||||| |||| 00| 0 eng d
028			_bWurzburg Road 35, BMC Premises, Post Code: 33102:
028			_b P. O. Box 1464, Mwanza – Tanzania:
028			_b Phone: +255 28 298 3384:
028			_bFax: +255 28 298 3386:
028			_bEmail: vc@bugando.ac.tz :
028			_b www.bugando.ac.tz
035			_a CUHAS/MD/4000901/T/12
040			_bEnglish _cDDC
041			_aEnglish
041			_aKiswahili
100			_a Omary, Hawa _d CUHAS/MD/4000901/T/12 _920286
245			_aDetermining the Association of Cervical Cancer and HIV Status at Ocean Road Cancer Institute.
260			_aMwanza, Tanzania: _bCatholic University of Health and Allied Sciences [CUHAS – Bugando] : _c©2017
300			_a57 Pages
300			_aIncludes References
520			_aAbstract: Background: Globally, carcinoma of the cervix ranks as the fourth cause of malignancy among women worldwide but the second common cancer in women age 15-44 years in the world and the seventh overall. It is estimated that 500,000 new cases diagnosed and 300,000 deaths occur every year. Worldwide mortality rates of cervical cancer are substantially lower than incidence with a ratio of mortality to incidence to 50.3%. The majority of cases are squamous cell carcinoma followed by adenocarcinomas. In Tanzania, carcinoma of cervix is the leading cause of purulent malignancy, not only among gynecological cancers but in all cancer. Estimated 35-45% of all cancer cases are due to cancer of cervix and 55-65% of all cancers in women. Current estimates indicate that 7,515 cases are diagnosed every year and 6,009 die of disease. Objective: To determine the association between cervical cancer and HIV status among women at Ocean Road Cancer Institute. Method: A cross-section study which involved 200 cervical cancer patients who were interviewed in their wards and clinical visit at Ocean Road Cancer Institute through a structured questionnaire. Results: From the study population of 200 cervical cancer patients 31 (15.5%) were seroconverted and the most affected age group were between 40-49 years 12 (6%) in which 13 (6.5%) were found in southern highland zone and lake zone 10 (5%) and none were found at university/college level. Maximum number of patient who were seroconverted were widow individuals 15 (7.5%) followed by married patients 13 (6.5%) and none of the of the cohabit had HIV. Majority of seroconverted cervical cancer patients were peasants 21 (10.5%), employed patients were few and had no HIV. Majority of individuals were ignorant of the risk factors associated with cervical cancer approximately all except few of them about (1.5%) who heard about contraceptive use. There was no association between cervical cancer stage and HIV status with a Chi square=8.015 and the p- value is 0.432 which is > than standard p-value of 0.05, and most of HIV positive patients were stage II, 15 (7.5%) followed by stage three, 7 (3.5%). Conclusion: In this study, HIV is the study, HIV is the predisposing factor for cervical cancer by 12%.
600			_xObstetrics and Gynecology
700			_aRumanyika, Richard. N _919984
942			_2ddc _cCR
999			_c20452 _d20452